154 related articles for article (PubMed ID: 16006750)
1. Increased antitumor activity in combined treatment TS-1 and docetaxel. A preclinical study using gastric cancer xenografts.
Takahashi I; Emi Y; Kakeji Y; Uchida J; Fukushima M; Maehara Y
Oncology; 2005; 68(2-3):130-7. PubMed ID: 16006750
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer.
Yoshida K; Hirabayashi N; Takiyama W; Ninomiya M; Takakura N; Sakamoto J; Nishiyama M; Toge T
Anticancer Res; 2004; 24(3b):1843-51. PubMed ID: 15274365
[TBL] [Abstract][Full Text] [Related]
3. [Three cases of advanced and recurrent gastric cancer treated with paclitaxel after TS-1 administration].
Fujiwara Y; Tamura S; Yoshioka S; Okada Y; Takiguchi S; Yano M; Yasuda T; Monden M
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2555-9. PubMed ID: 12506482
[TBL] [Abstract][Full Text] [Related]
4. Alternate-day oral therapy with TS-1 for advanced gastric cancer.
Arai W; Hosoya Y; Hyodo M; Yokoyama T; Hirashima Y; Yasuda Y; Nagai H; Shirasaka T
Int J Clin Oncol; 2004 Jun; 9(3):143-8. PubMed ID: 15221596
[TBL] [Abstract][Full Text] [Related]
5. [Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization].
Tasaka K; Okada Y; Tomofuji Y; Chinzei T
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1631-5. PubMed ID: 12355951
[TBL] [Abstract][Full Text] [Related]
6. [A trial of TS-1 administration on the basis of the pharmacokinetic study for an advanced gastric cancer patient with impaired renal function].
Yamamoto K; Imamura H; Furukawa H; Kishimoto T; Tanaka J; Oshiro R; Tatsuta M; Masutani S; Fukunaga M; Nakayama T; Takemoto H; Kondo M; Kamigaki S; Kawasaki T
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1748-51. PubMed ID: 16315929
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
Fukushima M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
[TBL] [Abstract][Full Text] [Related]
8. [A case of advanced gastric cancer with pulmonary carcinomatous lymphangiosis responding remarkably to combination chemotherapy of docetaxel (TXT) and TS-1].
Deguchi Y; Shioya M; Sakai M; Takenaka K; Doi H; Komai Y; Higuchi A
Gan To Kagaku Ryoho; 2005 Apr; 32(4):519-22. PubMed ID: 15853220
[TBL] [Abstract][Full Text] [Related]
9. Just when you thought the fluorouracil debate was over: S-1 and gastric cancer.
Ilson D
J Clin Oncol; 2005 Oct; 23(28):6826-8. PubMed ID: 16145059
[No Abstract] [Full Text] [Related]
10. Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.
Chu QS; Hammond LA; Schwartz G; Ochoa L; Rha SY; Denis L; Molpus K; Roedig B; Letrent SP; Damle B; DeCillis AP; Rowinsky EK
Clin Cancer Res; 2004 Aug; 10(15):4913-21. PubMed ID: 15297391
[TBL] [Abstract][Full Text] [Related]
11. [A surgical case of recurrent gastric cancer successfully treated by TS-1 plus low-dose consecutive administration of CDDP following TS-1 monotherapy].
Yamada Y; Kubo N; Ako E; Sawai Y
Gan To Kagaku Ryoho; 2002 Jan; 29(1):131-4. PubMed ID: 11816470
[TBL] [Abstract][Full Text] [Related]
12. [A pilot study of TS-1 combined with cisplatin in patients with advanced gastric cancer].
Iwase H; Shimada M; Nakamura M; Iyo T; Nakarai K; Kaida S; Indo T; Okeya M; Mizuno T; Ina K; Kusugami K
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1575-82. PubMed ID: 12355943
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
[TBL] [Abstract][Full Text] [Related]
14. A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.
Rino Y; Takanashi Y; Yukawa N; Saeki H; Wada H; Kanari M; Yamada R; Satoh T; Yamamoto N; Imada T
Anticancer Res; 2006; 26(2B):1455-62. PubMed ID: 16619558
[TBL] [Abstract][Full Text] [Related]
15. [A case of recurrent advanced gastric cancer with lung metastasis effectively treated by combined chemotherapy of TS-1 and weekly CDDP].
Shimoyama S; Kondo K; Kataoka M; Kinoshita M; Yamamura K; Kei F; Ohshima Y; Chin K; Hatsuno T; Kajikawa M; Miura K; Horisawa M
Gan To Kagaku Ryoho; 2004 Jan; 31(1):103-5. PubMed ID: 14750332
[TBL] [Abstract][Full Text] [Related]
16. [Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
Ohashi M; Kanda T; Yajima K; Banba T; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1640-2. PubMed ID: 16315894
[TBL] [Abstract][Full Text] [Related]
17. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].
Nakata B; Hirakawa K
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1962-8. PubMed ID: 15570921
[TBL] [Abstract][Full Text] [Related]
18. [A case of recurrent pleural effusion and positive cytology of advanced gastric cancer treated by TS-1 plus weekly taxane as second-line chemotherapy].
Akiba Y; Yamagishi Y; Mori S; Ueda T; Suzuki J; Hosoe N; Izumiya M; Takaishi H; Nagata H; Hibi T; Ishii H
Gan To Kagaku Ryoho; 2004 Mar; 31(3):453-6. PubMed ID: 15045961
[TBL] [Abstract][Full Text] [Related]
19. [A case of unresectable gastric cancer complicated by a serious hepatic disorder and Virchow lymph node metastasis in which FP therapy and TS-1 administration were effective].
Takemura M; Ohta Y; Shuto T; Takemura S
Gan To Kagaku Ryoho; 2002 Jun; 29(6):933-7. PubMed ID: 12090047
[TBL] [Abstract][Full Text] [Related]
20. [TS-1/CDDP therapy for advanced gastric cancer as neoadjuvant chemotherapy].
Nakamura M; Maruyama K; Furukawa J; Maruyama N; Tanaka J; Katsumoto Y; Yokouchi H; Nakaguchi K; Sue F; Yoshihara W
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1823-8. PubMed ID: 12402437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
